Elrexfio Interactions
There are 407 drugs known to interact with Elrexfio (elranatamab), along with 3 disease interactions. Of the total drug interactions, 57 are major, 335 are moderate, and 15 are minor.
- View all 407 medications that may interact with Elrexfio
- View Elrexfio disease interactions (3)
Most frequently checked interactions
View interaction reports for Elrexfio (elranatamab) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- acyclovir
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Addyi (flibanserin)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- Alhemo (concizumab)
- Altuviiio (antihemophilic factor)
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- amlodipine
- Amondys 45 (casimersen)
- Amvuttra (vutrisiran)
- Andembry (garadacimab)
- apremilast
- aspirin
- atorvastatin
- Attruby (acoramidis)
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- Bactrim (sulfamethoxazole / trimethoprim)
- Bafiertam (monomethyl fumarate)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Blenrep (belantamab mafodotin)
- Blincyto (blinatumomab)
- metformin
Elrexfio disease interactions
There are 3 disease interactions with Elrexfio (elranatamab) which include:
Report options
QR code containing a link to this page
More about Elrexfio (elranatamab)
- Elrexfio consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
